Improving community participation to eliminate lymphatic filariasis in American Samoa

Acta Trop. 2011 Sep:120 Suppl 1:S48-54. doi: 10.1016/j.actatropica.2010.08.021. Epub 2010 Oct 30.

Abstract

In 2000, the American Samoa Department of Health initiated a campaign of annual mass drug administration (MDA) with albendazole and diethylcarbamazine (DEC) to eliminate transmission of filariasis. Drug coverage was well below prescribed targets in the first three campaigns, ranging from 24 to 52% of the total population. Evaluation findings from a variety of formative research methods identified opportunities to improve MDA coverage and ensuing program modifications resulted in increased drug coverage of 65-71% in the following four annual distributions. Partnering with churches for drug distribution and using multiple media channels for health promotion led to sustained program improvements. With the increased emphasis on the use of mass distribution for delivery of drugs for a number of neglected tropical diseases, other programs may benefit from a similar approach.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Albendazole / administration & dosage*
  • Albendazole / therapeutic use
  • American Samoa / epidemiology
  • Animals
  • Anthelmintics / administration & dosage*
  • Anthelmintics / therapeutic use
  • Community Participation*
  • Diethylcarbamazine / administration & dosage*
  • Diethylcarbamazine / therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Elephantiasis, Filarial / drug therapy*
  • Elephantiasis, Filarial / epidemiology*
  • Family Characteristics
  • Filaricides / administration & dosage*
  • Filaricides / therapeutic use
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Prevalence
  • Program Evaluation
  • Sentinel Surveillance
  • Surveys and Questionnaires
  • Wuchereria bancrofti / drug effects*

Substances

  • Anthelmintics
  • Filaricides
  • Albendazole
  • Diethylcarbamazine